+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biophotonics - Global Strategic Business Report

  • PDF Icon

    Report

  • 214 Pages
  • May 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2228011
The global market for Biophotonics is estimated at US$99.3 Billion in 2023 and is projected to reach US$203.1 Billion by 2030, growing at a CAGR of 10.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the See-through Imaging Application segment, which is expected to reach US$30.7 Billion by 2030 with a CAGR of a 0%. The Inside Imaging Application segment is also set to grow at 8.8% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $30.1 Billion in 2023, and China, forecasted to grow at an impressive 10.3% CAGR to reach $35.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biophotonics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biophotonics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biophotonics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as F. Hoffmann-La Roche AG, GE Healthcare, Horiba Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 83 Featured):

  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • IDEX Corporation
  • IPG Photonics Corporation
  • Koninklijke Philips NV
  • Procter & Gamble Company, The
  • Qiagen, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biophotonics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Tests & Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Medical Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Non-Medical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for See-through Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Inside Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Spectro Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Surface Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 29: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 30: World 16-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 32: World Historic Review for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 33: World 16-Year Perspective for Light Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 35: World Historic Review for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 36: World 16-Year Perspective for Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 37: World Recent Past, Current & Future Analysis for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 38: World Historic Review for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 39: World 16-Year Perspective for Non-Medical Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 40: World Biophotonics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 41: USA Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: USA Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: USA 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 44: USA Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: USA Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: USA 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
CANADA
  • Table 47: Canada Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Canada Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Canada 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 50: Canada Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Canada Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Canada 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
JAPAN
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 53: Japan Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Japan Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Japan 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 56: Japan Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Japan Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Japan 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
CHINA
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 59: China Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: China Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: China 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 62: China Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: China Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: China 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
EUROPE
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 65: Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 69: Europe Historic Review for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Europe 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 71: Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
FRANCE
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 74: France Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: France Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: France 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 77: France Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: France Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: France 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
GERMANY
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 80: Germany Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Germany Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Germany 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 83: Germany Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Germany Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Germany 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
ITALY
  • Table 86: Italy Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Italy Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Italy 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 89: Italy Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Italy Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Italy 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 92: UK Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: UK Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: UK 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 95: UK Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: UK Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: UK 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Rest of Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 109: Asia-Pacific 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • IDEX Corporation
  • IPG Photonics Corporation
  • Koninklijke Philips NV
  • Procter & Gamble Company, The
  • Qiagen, Inc.

Table Information